Cannabis Stocks are on the Rise Without Legalization in 2026

The planned change in the federal classification of marijuana in the United States has attracted the attention of the media and investors. President Trump is preparing an executive order, possibly for the last days of 2025 or the beginning of 2026, in which he would re-classify cannabis: moving it from the strictest federal category I to category III.

Despite speculation by many, this move does not mean full legalization or decriminalization of marijuana. However, it has a significant impact on scientific testing of cannabis, as well as on the cannabis market and related assets. So how can investors take advantage of this opportunity?

New Cannabis Law

According to the Washington Post, moving cannabis to Schedule III would reduce its regulation to the level of substances with low to moderate addiction risk, similar to prescription drugs containing codeine or anabolic steroids. This would separate marijuana from the most controlled drugs such as heroin and LSD, facilitating trade and scientific research on cannabis. However, experts point out that the average consumer may not even notice the changes; the stronger impact will be felt by legal businesses and drug research.

The new cannabis law under preparation also discusses clear rules for growers and sellers, which could include limits on the amount of marijuana allowed for personal and medical use. This is key information for investors, as clearly defined rules reduce the risk of regulatory uncertainty and increase market stability.

For companies operating in the cannabis industry, this step is also significant from a financial perspective. Until now, high federal taxes and regulatory uncertainty have complicated business, with the tax burden for many sellers exceeding 70%. According to some experts, the reclassification could reduce these barriers, open the door to banks that have so far refused to provide services to the sector, and improve companies’ access to major US stock exchanges. This means that cannabis companies could become more accessible to institutional investors, which could lead to a significant increase in their valuation.

Cannabis Companies Shares

The market has already reacted sharply and positively to all this. Anyone who frequently uses investment apps could not have overlooked the reports of incredible growth in cannabis shares in recent days and hours. For example, Tilray Brands (TLRY) shares in New York rose by approximately 48% intraday. Canopy Growth (CAD) shares on the Toronto Stock Exchange pleased their shareholders even more with an intraday increase of 65%. Other well-known companies, such as SNDL and Amplify Seymour Cannabis ETF, added between 20 and 37 percent.

This momentum confirms that investors expect a significant growth cycle for the entire sector. According to some analysts, this is the beginning of potentially long-term growth, rather than just a short-term and fleeting market reaction.

However, the current valuation of the sector is still relatively low. Overall, cannabis companies are trading at approximately one times revenue and around 6.5 times adjusted EBITDA, which is highly attractive given the growth prospects. Nevertheless, the market remains cautious: even after Friday’s sharp rise, the shares of some companies, such as the aforementioned Tilray Brands, have still not exceeded the levels seen in August this year, when Trump first hinted at the possibility of reclassification. This reflects expectations that regulatory processes may be lengthy and that the effects will be gradual.

The issue of marijuana legality in the US remains extremely complex. Recreational use is legal in 24 states, medical use in 40, and the federal ban theoretically allows for action to be taken against legal businesses. Nevertheless, Colorado has collected over $3 billion in taxes since legalizing cannabis in 2014 through September 2025. This once again demonstrates the economic potential of the industry. Clearly defined permitted amounts of marijuana for individuals and businesses contribute to a transparent business environment and reduce the risk of conflict with the law.

Legalization of Marijuana Globally, and Investment Opportunities

A global perspective also helps in developing a strategy for investing in cannabis companies. The legalization of marijuana around the world is progressing at different speeds, from full recreational legalization in Canada and parts of Europe to partial legalization for medical purposes in South America and Australia. The cannabis sector is not isolated and can benefit from international trends, export growth, and foreign capital inflows. Monitoring these global changes is important for estimating the future growth of cannabis company shares and the value of the entire industry.

It is crucial for investors to note that although there is still little to no chance of marijuana legalization at the federal level in the US, the reclassification itself and the new cannabis law in the pipeline could fundamentally change the financial environment for cannabis companies. It will allow access to banks, stock exchanges, and institutional investors, which could significantly affect the share price of cannabis companies in the coming months.

According to experts and experienced investors, the cannabis sector is still in the early stages of its growth cycle and therefore represents an interesting investment opportunity for those seeking attractive returns in a relatively new but dynamically developing segment.

Disclaimer: This article is for informational purposes only and does not constitute an investment recommendation. Any information contained in this article is for educational and guidance purposes only and should not be considered as specific investment advice. Before making any investment decision, it is recommended that you consult with experts or financial advisors who can provide personalized and professional recommendations based on your individual needs and circumstances.
Sign up for our newsletter
  • Souhlasím se zpracováním osobních údajů a Obchodními podmínky.

Read more:

Load more
We only allow logged-in users to post reviews on our website to ensure authenticity and reliability while avoiding spam. If you have not created an account yet, please go through the simple registration process.